<var id="j1dh7"><strike id="j1dh7"></strike></var><var id="j1dh7"><strike id="j1dh7"><thead id="j1dh7"></thead></strike></var>
<ins id="j1dh7"><span id="j1dh7"><thead id="j1dh7"></thead></span></ins>
<var id="j1dh7"></var>
<cite id="j1dh7"><strike id="j1dh7"><listing id="j1dh7"></listing></strike></cite><cite id="j1dh7"><strike id="j1dh7"><listing id="j1dh7"></listing></strike></cite>
<cite id="j1dh7"><video id="j1dh7"></video></cite>
<var id="j1dh7"></var>
<var id="j1dh7"></var>
<cite id="j1dh7"><span id="j1dh7"><var id="j1dh7"></var></span></cite>
<cite id="j1dh7"></cite><cite id="j1dh7"><span id="j1dh7"></span></cite>

BioLife Solutions to take over bio materials storage provider SciSafe
Category: #headline  By Mateen Dalal  Date: 2020-09-23
  • share
  • Twitter
  • Facebook
  • LinkedIn

BioLife Solutions to take over bio materials storage provider SciSafe

Leading bio-production tools supplier, BioLife Solutions Inc, has reportedly signed a definitive agreement for the acquisition of biological materials storage provider, SciSafe. SciSafe is known for delivering biological materials storage to pharmaceutical industries and the cell and gene therapy market. The deal is likely to be closed on September 30, state sources.

According to Mike Rice, the CEO of BioLife Solutions, this takeover allows BioLife to deliver additional value to its cell and gene therapy clientele via an established business that has a seasoned team, excellent reputation, and marquee customers. He has further added that the company is advancing towards profitable growth through this acquisition and intends to initiate expansion into the high augmentation biostorage segment with a vigorous financial performance, strong quality system, and scalable business model.

Rice has also stated that BioLife anticipates numerous facilities for the cGMP storage of its biopreservation media products and leverages CBS facility for the purpose of manufacturing walk-in freezer rooms for SciSafe, adding that the company also intends to utilize the company’s evoIS cloud app and evo Smart Shippers for thousands of annual outbound and inbound biologic materials shipments that are monitored by SciSafe.

For the record, SciSafe had unaudited earnings of $6 million in 2019 which are expected to be accretive over 2021. As per the terms of the acquisition, BioLife will pay a sum of $15 million in cash and also invest additional $15 million in recently issued BioLife common stock shares for 100 per cent of the outstanding SciSafe shares. SciSafe’s shareholders will also be eligible for receiving up to 626,000 more shares of BioLife common stock over the upcoming four years subject to the realization of milestones in annual proceeds.

Garrie Richardson, the President of SciSafe, has stated that the SciSafe team will offer remarkable high-margin incremental proceeds to BioLife’s growing business through the effective deployment of its financial resources, key customer relationships, and commitment towards the company’s growth.

 

Source Credits:

https://investors.biolifesolutions.com/2020-09-21-BioLife-Solutions-to-Acquire-SciSafe-a-High-Growth-Biostorage-Service-Provider-to-the-Cell-and-Gene-Therapy-Industry

About Author

Mateen Dalal    

Mateen Dalal

Despite working as a professional testing engineer, Mateen Dalal always held a liking for content creation. Following his passion, he now pens down articles for itresearchbrief.com and a couple of similar portals. Mateen is a qualified electronics and telecommunicat...

Read More>>

More News By Mateen Dalal

UNICEF urges G7 to donate unused Covid shots to vaccine-sharing scheme
UNICEF urges G7 to donate unused Covid shots to vaccine-sharing scheme
By Mateen Dalal

UNICEF, the United Nations agency responsible for providing humanitarian and developmental help to c...

Biopharma startup Telix begins Phase III prostate cancer therapy trial
Biopharma startup Telix begins Phase III prostate cancer therapy trial
By Mateen Dalal

Telix Pharmaceuticals Ltd., an Australia-based pharmaceutical company, has reportedly received Human...

Health Canada reduces age eligibility of Pfizer’s COVID-19 shot to 12
Health Canada reduces age eligibility of Pfizer’s COVID-19 shot to 12
By Mateen Dalal

Reportedly, Health Canada has authorized the use of COVID-19 vaccine which is manufactured by Pfizer...


性XXXX欧美老妇胖老太,欧美人禽杂交狂配,亚洲老汉色Av影院在线,日韩AV在线